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1

We examined breast cancer risk in association with overall glycemic index (GI), glycemic load (GL), and dietary carbohydrate and
sugar intake in a prospective cohort of 49,613 Canadian women
enrolled in the National Breast Screening Study who completed a
self-administered food frequency questionnaire between 1980 and
1985. Linkages to national mortality and cancer databases yielded
data on deaths and cancer incidence, with follow-up ending between 1998 and 2000. During a mean follow-up of 16.6 years, we
observed 1,461 incident breast cancer cases. GI, GL, total carbohydrate and total sugar intake were not associated with breast
cancer risk in the total cohort. However, there was evidence of
effect modiﬁcation of the association between GI and breast cancer risk by menopausal status (p ⴝ 0.01), the hazard ratio for the
highest versus the lowest quintile level of GI being 0.78 (95% CI ⴝ
0.52–1.16; ptrend ⴝ 0.12) in premenopausal women and 1.87 (95%
CI ⴝ 1.18 –2.97; ptrend ⴝ 0.01) in postmenopausal women. The
associations between GI and GL were not modiﬁed by body mass
index (BMI) or by vigorous physical activity among pre- or postmenopausal women. Similarly, the associations between GI/GL
and risk in postmenopausal women were not modiﬁed by BMI,
vigorous physical activity, or ever use of hormone replacement
therapy (HRT), although the associations were slightly stronger
among those who reported no vigorous physical activity (ptrend ⴝ
0.02), among those who reported ever using HRT (ptrend ⴝ 0.02)
and among normal-weight women (BMI < 25 kg/m2; ptrend ⴝ
0.03). Our data suggest that consumption of diets with high GI
values may be associated with increased risk of breast cancer
among postmenopausal women, possibly more so among subgroups deﬁned by participation in vigorous physical activity, ever
use of HRT and those who are not overweight.
© 2004 Wiley-Liss, Inc.
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Glycemic index (GI) is a means of classifying the carbohydrate
content of individual foods according to their postprandial glycemic effects and hence their effects on blood insulin levels.1–3
Using glycemic index values and the carbohydrate content of
foods, the total glycemic effect of the diet (glycemic load) can be
estimated.4 Consumption of high GI diets has been associated with
hyperinsulinemia,1,4,5 while low GI diets have been shown to be
associated with a lower postprandial rise in insulin,6 thus maintaining insulin sensitivity.7
Hyperinsulinemia has been shown to be associated with increased breast cancer risk,8,9 and it is conceivable that this reﬂects
an underlying association with high glycemic index diets. To date,
there have been several studies of the association between dietary
glycemic load and glycemic index and breast cancer risk.10 –15 The
results of 3 of these investigations were null,11,12,14 whereas the
other 3 studies observed associations either overall15 or within
subgroups deﬁned by physical activity13 or obesity.10 Given the
mixed results of previous studies, we examined the relationship
between overall glycemic index and glycemic load, as well as total
carbohydrate and total sugar consumption (included because of
their strong association with postprandial insulin response16), and
breast cancer risk in a prospective cohort study of Canadian
women. We examined risk overall and across strata deﬁned by
menopausal status, body mass index (BMI), physical activity and
hormone replacement therapy (HRT) use.
Publication of the International Union Against Cancer

Material and methods
Study population
The study, which has been described in detail elsewhere,17 was
conducted among participants in the Canadian National Breast
Screening Study (NBSS), a randomized controlled trial of screening for breast cancer.18 A total of 89,835 women aged 40 –59 years
were recruited into the trial between 1980 and 1985.
Questionnaires
At recruitment into the study, participants completed a selfadministered questionnaire that sought information on demographic characteristics, lifestyle factors, menstrual and reproductive history, as well as use of oral contraceptives and replacement
estrogens. Starting in 1982 (that is, after some participants had
completed their scheduled visits to the screening centers), a selfadministered food frequency questionnaire (FFQ) was distributed
to all new attendees at all screening centers and to women returning to the screening centers for rescreening.19 The FFQ sought
information on usual portion size and frequency of consumption of
86 food items and included photographs of various portion sizes to
assist respondents with quantifying intake. A comparison between
the self-administered questionnaire and a full interviewer-administered questionnaire, which has been subjected to both validity
and reliability testing19 and used in a number of epidemiologic
studies,20 revealed that the 2 methods gave estimates of intake of
the major macronutrients and dietary ﬁber that were moderately to
strongly correlated with each other (reported correlation coefﬁcients ranged from 0.47 to 0.72).19 A total of 49,613 dietary
questionnaires were returned and available for analysis.
Calculation of nutrient intake, overall glycemic index and
glycemic load
Data from the completed self-administered food frequency
questionnaires were used to estimate daily intake of nutrients using
a database for Canadian foods that has been described elsewhere.20
Data from the food frequency questionnaire were also used to
estimate overall glycemic index and glycemic load. Glycemic
index values of foods were obtained from published reports based
on studies in North America.4 Overall glycemic index was calculated by multiplying the carbohydrate content (in grams) of a given
food item by the number of servings per day of that food item and
its glycemic index value, summing all food items reported and
dividing by the total carbohydrate in the diet. Total dietary glycemic load was calculated by multiplying the carbohydrate content
of a given food item by the number of servings consumed per day
and its glycemic index value and summing the values for all food
items reported. Each unit increase in glycemic load represents the
insulin response to the equivalent of 1 g glucose or carbohydrate
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from white bread (depending on the standard used).21 When the
reported glycemic index values for foods were observed to vary
across studies,4 we used the mean of the reported values of
glycemic index for that food. The main foods contributing to
glycemic load in the cohort are listed in a footnote to Table I.
Ascertainment of incident breast cancer cases and deaths
Cases were women who were diagnosed during follow-up with
incident breast cancer, ascertained by means of computerized
record linkage to the Canadian Cancer Database. Deaths were
ascertained by means of record linkage to the National Mortality
Database. Both of these databases are maintained by Statistics
Canada. The linkages to the databases yielded data on cancer
incidence and mortality to 31 December 2000 for women in
Ontario, 31 December 1998 for women in Quebec and 31 December 1999 for women in other provinces in Canada. Among the
women for whom dietary data were available, we identiﬁed 1,461
incident breast cancers.
Statistical analysis
Of the 49,613 women with dietary data, we excluded women
with extreme energy intake values (at least 3 standard deviations
above or below the mean value for loge caloric intake; n ⫽ 502).
These exclusions left 49,111 women available for analysis, among
whom there were 1,450 incident cases of breast cancer.
Cox proportional hazards models (using age as the time scale)
were used to estimate hazard ratios (HRs) and 95% conﬁdence
intervals (CIs) for the association between energy-adjusted quintile
levels of glycemic load, overall glycemic index, total carbohydrates and total sugar, as well as breast cancer risk; energy adjustment was performed using the residual method.22 For these analyses, cases contributed person-time to the study from their date of
enrollment until the date of diagnosis of their breast cancer, and
noncases contributed person-time from their date of enrollment
until the termination of follow-up (the date to which cancer incidence data were available for women in the corresponding province) or death, whichever occurred earlier. Multivariate models
included the variables listed in the footnote of Table II. To test for
trend, we ﬁtted the median value of each quintile as an ordinal
variable in the risk models and evaluated the statistical signiﬁcance

of the coefﬁcient using the Wald test.23 We examined the associations overall and within strata deﬁned by menopausal status.
Women who reported having regular menstrual periods within the
past 12 months or who had had a hysterectomy without bilateral
oophorectomy and were less than 45 years of age were classiﬁed
as premenopausal. Women whose menstrual periods ceased prior
to 12 months before baseline, those who had had a bilateral
oophorectomy and those who had had a hysterectomy and were
over 55 years of age were considered postmenopausal.24 In addition, the associations overall and within menopausal strata were
examined further within subgroups deﬁned by body mass index
[deﬁned as weight (kg)/height (m2); weight and height were measured at baseline25], self-reported vigorous physical activity (deﬁned as jogging, running, brisk walking, vigorous sport, bicycling,
heavy housework, etc.) and use of hormone replacement therapy
(ever vs. never). Given the relatively small number of cases within
each stratum of pre- and postmenopausal women, we categorized
overall glycemic index and glycemic load by quartiles for the latter
analyses. Stratum-speciﬁc multivariate models included the variables listed in a footnote in Table III. Interaction effects were
tested independently of each other such that in the analysis of
interaction with BMI, physical activity and HRT use were controlled for; in the analysis of interaction with physical activity,
BMI and HRT use were controlled for; and in the analysis of
interaction with HRT use, BMI and physical activity were controlled for. Tests for interaction were based on likelihood ratio tests
comparing models with and without product terms representing the
variables of interest. Use of the life test procedure in SAS showed
that the proportional hazards assumption was met in this data set.
All analyses were performed using SAS version 9 (SAS Institute,
Cary, NC).
Results
The average duration of follow-up for cohort members was 16.6
years, corresponding to a total of 811,649 person-years of follow-up for the cohort. The mean age at diagnosis for the cases was
54.8 ⫾ 6.5 years. For the cohort as a whole, the mean ⫾ SD of the
energy-adjusted overall glycemic index and glycemic load were
74.6 ⫾ 12.2 and 144.5 ⫾ 42.5 g/day, respectively. There was a

TABLE I – AGE-ADJUSTED BASELINE DISTRIBUTIONS OF BREAST CANCER RISK FACTORS BY QUINTILES OF ENERGY-ADJUSTED GLYCEMIC LOAD
Quintiles of energy-adjusted glycemic load (g/day)
⬍119

Mean overall glycemic index
Mean glycemic load (g/day)
Mean total carbohydrates (g/day)
Mean total sugar (g/day)
Mean total ﬁber (g/day)
Mean energy intake (kcal/day)
Mean age (years)
Postmenopausal at baseline (%)
Mean BMI (kg/m2)
Ever smoker (%)
Mean alcohol intake (g/day)
Some vigorous physical activity (%)
Age at menarche ⱕ 12 years (%)
Mean duration of oral contraceptive
use (months)
Mean duration of hormone
replacement therapy use (months)2
Mean number of live births
First-degree relative with breast cancer
(% yes)
Age at ﬁrst birth

120–139

140–155

156–175

⬎ 175

72.5 (53.7)*
98.6 (28.7)
149.8 (137.9)
58.7 (73.3)
17.4 (14.3)
2106 (1442)
48.1 (5.5)
18.0
25.2 (10.2)
24.9
16.1 (28.0)
18.8
20.8
37.6 (108.6)

78.4 (53.6)
129.5 (28.7)
179.0 (137.8)
71.6 (73.2)
20.0 (14.3)
2027 (1441)
48.4 (5.5)
19.4
25.1 (10.2)
21.7
10.0 (27.9)
20.5
20.7
35.7 (108.6)

79.7 (53.6)
147.2 (28.7)
198.6 (137.8)
79.6 (73.2)
21.2 (14.3)
2046 (1441)
48.5 (5.7)
19.8
24.7 (10.2)
19.3
7.6 (27.9)
20.8
20.4
33.8 (108.6)

81.7 (53.7)
164.5 (28.7)
216.6 (137.8)
86.3 (73.2)
22.1 (14.3)
2059 (1441)
48.8 (5.7)
21.1
24.6 (10.2)
17.8
5.5 (27.9)
21.0
19.4
32.0 (108.6)

84.3 (53.7)
196.0 (28.7)
253.9 (137.9)
103.0 (73.3)
23.2 (14.3)
2121 (1441)
48.9 (5.7)
21.9
24.3 (10.2)
16.4
3.6 (27.8)
19.1
18.8
28.3 (108.6)

14.4 (85.3)

13.5 (85.2)

13.1 (85.2)

12.6 (85.2)

13.7 (85.2)

2.6 (6.1)
20.0

2.6 (6.1)
19.8

2.6 (6.1)
20.5

2.6 (6.1)
20.5

2.6 (6.1)
19.3

23.8 (10.5)

24.2 (10.4)

24.4 (10.4)

24.5 (10.4)

24.6 (10.5)

1

*The main foods contributing to glycemic load in the cohort include white bread (sliced), rolls, mufﬁns, potatoes (baked, boiled, mashed),
French fries, cakes, cookies, rice, pasta, pizza, cold breakfast cereals, pies and tarts, cola, other soft drinks, citrus fruits and juices and other fruits,
crisp snacks (such as potato chips or popcorn), candy, chocolate, peas, beans and lentils, hot breakfast cereals, dark and whole grain breads, corn,
root vegetables other than potatoes, jam, jelly and honey, sugar in tea or coffee, icecream, peanut butter.–1Numbers in parentheses represent the
standard deviation.–2Among postmenopausal women only.
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TABLE II – ADJUSTED HAZARD RATIOS AND 95% CONFIDENCE INTERVALS FOR THE ASSOCIATION BETWEEN OVERALL
GLYCEMIC INDEX AND GLYCEMIC LOAD AND RISK OF BREAST CANCER
Cases/person-years

Glycemic load (g/day)
⬍ 119
120–139
140–155
156–175
⬎ 175
p for trend
Overall glycemic index
⬍ 60
61–71
72–81
82–96
⬎96
p for trend
Total carbohydrate (g/day)
⬍143
144–175
176–206
207–249
⬎249
p for trend
Total sugar (g/day)
⬍ 52
53–68
69–83
84–103
⬎ 103
R for Trend

Hazard ratio (95% CI)
Age and energy adjusted

Multivariate adjusted

297/163,012
285/162,580
300/162,186
286/162,307
282/161,563

1.0 (referent)
0.95 (0.80–1.13)
1.03 (0.87–1.22)
1.00 (0.84–1.19)
1.00 (0.84–1.18)
0.84

1.0 (referent)
0.95 (0.80–1.14)
1.02 (0.86–1.22)
0.97 (0.81–1.16)
0.95 (0.79–1.14)
0.70

293/161,898
307/162,474
281/162,182
287/162,623
282/162,471

1.0 (referent)
0.99 (0.81–1.21)
0.91 (0.72–1.15)
0.93 (0.71–1.22)
0.88 (0.64–1.21)
0.41

1.0 (referent)
1.01 (0.82–1.24)
0.94 (0.74–1.19)
0.96 (0.73–1.26)
0.88 (0.63–1.22)
0.38

284/162,780
302/162,771
265/162,475
323/162,366
276/161,257

1.0 (referent)
1.11 (0.93–1.17)
0.92 (0.76–0.96)
1.18 (0.97–1.13)
1.01 (0.79–0.93)
0.67

1.0 (referent)
1.09 (0.91–1.31)
0.90 (0.74–1.11)
1.12 (0.90–1.38)
0.93 (0.70–1.22)
0.86

284/162,201
284/162,631
315/162,812
291/162,443
276/161,562

1.0 (referent)
1.02 (0.86–1.22)
1.14 (0.96–1.36)
1.08 (0.89–1.30)
1.00 (0.81–1.24)
0.74

1.0 (referent)
1.00 (0.84–1.20)
1.08 (0.90–1.30)
0.98 (0.80–1.20)
0.88 (0.70–1.12)
0.38

Multivariable models included age (age at baseline), BMI in kg/m2 (⬍ 25, 25–29, ⱖ 30), menopausal status, alcohol (zero plus 4 levels of
intake), use of hormone replacement therapy (never plus four levels of duration), use of oral contraceptives (never plus four levels of duration),
parity (zero plus 3 levels), age at menarche (ⱕ 12 vs. ⬎ 12 years of age), age at ﬁrst live birth (⬍ 25, 25–29, ⱖ 30), ﬁrst-degree relative with
breast cancer (yes/no), history of benign breast disease (yes/no), intake of energy (as a continuous variable), energy-adjusted total ﬁber intake
(as a continuous variable), study center and randomization group.
TABLE III – ADJUSTED HAZARD RATIOS AND 95% CONFIDENCE
INTERVALS FOR THE ASSOCIATION BETWEEN OVERALL GLYCEMIC
INDEX AND GLYCEMIC LOAD AND RISK OF BREAST CANCER
STRATIFIED BY MENOPAUSAL STATUS
Hazard ratio (95% CI)

No. of cases/person years

Premenopausal

Postmenopausal

670–400,673

575/300,048

Glycemic load (g/day)
⬍125
1.0 (referent)
125–147
0.95 (0.76–1.18)
148–169
0.81 (0.64–1.02)
⬎ 169
0.96 (0.76–1.22)
p ⫽ 0.44
Overall glycemic index
⬍63
1.0 (referent)
64–76
0.95 (0.73–1.23)
77–92
0.77 (0.55–1.06)
⬎92
0.78 (0.52–1.16)
p ⫽ 0.12

p for
interaction

1.0 (referent)
1.18 (0.92–1.54)
1.20 (0.93–1.56)
1.08 (0.82–1.41)
p ⫽ 0.68

0.08

1.0 (referent)
1.43 (1.04–1.97)
1.80 (1.24–2.62)
1.87 (1.18–2.97)
p ⫽ 0.01

0.01

Multivariable models included age (age at baseline), BMI in kg/m2
(⬍ 25, 25–29, ⱖ 30), alcohol (zero plus levels of intake), use of
hormone replacement therapy (never plus 4 levels of duration), use of
oral contraceptives (never plus 4 levels of duration), parity (zero plus
3 levels), age at menarche (ⱕ 12 vs. ⬎ 12 years of age), age at ﬁrst live
birth (⬍ 25, 25–29, ⱖ 30), ﬁrst-degree relative with breast cancer
(yes/no), history of benign breast disease (yes/no), intake of energy (as
a continuous variable), energy-adjusted total ﬁber intake (as a continuous variable), study center and randomization group.

2-fold variation in mean glycemic load values between the lowest
and highest quintile levels (Table I).
Compared to those with relatively low glycemic load values,
women with high glycemic load values reported lower alcohol
consumption, were less likely to have ever smoked, had a shorter

mean duration of oral contraceptive use, had a longer mean duration of hormone replacement therapy, had slightly lower mean
body mass index, were more likely to be postmenopausal at
baseline, were less likely to have a relatively early age at menarche
and consumed more total carbohydrates, sugar and ﬁber (Table I).
No appreciable variation was observed in mean energy intake,
participation in vigorous physical activity, parity, or age at ﬁrst
birth by quintile levels of glycemic load. The patterns for overall
glycemic index were similar to those for the glycemic load (data
not shown).
Table II shows that in age- and energy-adjusted models, there
was no association between glycemic load, overall glycemic index,
total carbohydrate, or total sugar intake and risk of breast cancer.
After multivariate adjustment, the hazard ratios remained essentially unchanged.
Risk of breast cancer associated with glycemic load differed
little between premenopausal and postmenopausal women. However, there was some suggestion of effect modiﬁcation of the
association between overall glycemic index and breast cancer risk
by menopausal status (Table III). Among premenopausal women,
the highest versus the lowest quartile level of overall glycemic
index was associated with a 22% reduction in risk (95% CI ⫽
0.52–1.16; ptrend ⫽ 0.12), while among postmenopausal women,
the highest versus lowest quartile level of overall glycemic index
was associated with an 87% increased risk of breast cancer (95%
CI ⫽ 1.18 –2.97; ptrend ⫽ 0.01). On formal testing, the interaction
between overall glycemic index and menopausal status was statistically signiﬁcant [chi-square (3) ⫽ 12.05; p ⫽ 0.01]. There was no
association between total sugar intake and breast cancer risk
among pre- or postmenopausal women (ptrend ⫽ 0.74 and 0.19,
respectively; data not shown). Likewise, total carbohydrate consumption was not associated with risk among either pre- or postmenopausal women (ptrend ⫽ 0.73 and 0.58, respectively; data not
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shown). On formal testing, menopausal status did not modify the
association between either total sugar intake [chi-square (3) ⫽
2.34; p ⫽ 0.50] or total carbohydrate consumption [chi-square
(3) ⫽ 2.94; p ⫽ 0.40] and breast cancer risk.
Within the total study population, there was no evidence of
effect modiﬁcation of the association between glycemic load and
overall glycemic index and breast cancer risk by BMI or vigorous
physical activity (data not shown). Likewise, Table IV shows that
the associations between glycemic load and overall glycemic index
and breast cancer risk among premenopausal women were not
modiﬁed by BMI or vigorous physical activity. In addition, BMI
and participation in vigorous physical activity did not modify the
association between either total sugar intake or total carbohydrate
intake and breast cancer risk (data not shown).
Table V shows the associations between glycemic load and
overall glycemic index and breast cancer risk among postmenopausal women, stratiﬁed by BMI, participation in vigorous physical activity and HRT use. As with premenopausal women, the
association between glycemic load and breast cancer risk among
postmenopausal women did not appear to be modiﬁed by any of
these variables. With respect to overall glycemic index, the highest
versus lowest quartile level was associated with increased risk
among both overweight/obese (HR ⫽ 1.57; 95% CI ⫽ 0.78 –3.13;
ptrend ⫽ 0.25) and normal weight postmenopausal women (HR ⫽
1.99; 95% CI ⫽ 1.06 –3.72; ptrend ⫽ 0.03). As well, among women
who participated in vigorous physical activity, the highest versus
lowest quartile level of overall glycemic index was associated with
a 78% increase in risk (95% CI ⫽ 0.76 – 4.18; ptrend ⫽ 0.26), while
a hazard ratio of 1.86 (95% CI ⫽ 1.07–3.21; ptrend ⫽ 0.02) was
observed for the highest versus the lowest quartile level among
postmenopausal women who did not participate in any vigorous
physical activity. Furthermore, among ever users of HRT, the
highest versus lowest quartile level of overall glycemic index was
associated with a 2.2-fold increased risk of breast cancer (95%
CI ⫽ 1.16 – 4.00; ptrend ⫽ 0.02), whereas among never users, there
was a 58% (95% CI ⫽ 0.79 –3.18; ptrend ⫽ 0.27) increased risk of
breast cancer at the uppermost quartile level. There was no statistical evidence for interactions between overall glycemic index and
BMI [chi-square (3) ⫽ 2.01; p ⫽ 0.57], participation in vigorous
physical activity [chi-square (3) ⫽ 2.10; p ⫽ 0.55], or HRT use
[chi-square (3) ⫽ 2.09; p ⫽ 0.55] in relation to breast cancer risk
among postmenopausal women. Similarly, the associations between total sugar intake and total carbohydrate intake and risk of
breast cancer did not appear to be modiﬁed by BMI, participation
in vigorous physical activity, or HRT use among postmenopausal
women (data not shown).

Discussion
High glycemic index diets are associated with increased insulin
secretion,1,4,5,26 which may affect breast cancer risk by several
mechanisms, including alteration of cell cycle kinetics (insulin
facilitates the transit of cells through the G1 phase of the cell
cycle),27 inhibition of apoptosis28 and elevation of plasma estrogen
levels via lower production of sex hormone-binding globulin.29
In the prospective study reported here, there was no association
between either overall glycemic index or glycemic load and breast
cancer risk over a 16-year follow-up period in the total study population. Likewise, no association was found between either total sugar
or total carbohydrate intake and risk of breast cancer. There was some
suggestion of increased risk in association with overall glycemic
index among women who were postmenopausal at baseline, while
statistically nonsigniﬁcant reductions in risk were observed at each
level of overall glycemic index (above that for the reference category)
among premenopausal women. The differences between pre- and
postmenopausal women were characterized further upon stratiﬁcation
by body mass index (kg/m2) and participation in vigorous physical
activity, wherein small, statistically nonsigniﬁcant decreases in risk
were observed in association with glycemic load and overall glycemic
index within strata of BMI and participation in vigorous physical
activity among premenopausal women, and positive associations were
found within strata of BMI and vigorous physical activity in postmenopausal women. In postmenopausal women, there were also
increases in risk within strata deﬁned by HRT use. There was some
suggestion that the associations were slightly stronger among women
who had ever used HRT and those who never participated in vigorous
physical activity, but there was no statistical evidence of effect modiﬁcation by these variables.
In our study population, glycemic load was not associated with
risk, whereas overall glycemic index was associated with breast
cancer risk within speciﬁc subgroups. In trying to understand these
differences, it is important to note that these indexes reﬂect slightly
different characteristics of dietary carbohydrate intake. Overall
glycemic index provides information on overall carbohydrate quality in the diet by comparing the effect of isoenergetic intakes of
carbohydrate, while total dietary glycemic load, by taking into
account the amount of carbohydrate consumed, provides information on both the quality and quantity of total dietary carbohydrate
intake.4 Thus, while the study participants who developed breast
cancer may have consumed a wider variety of high glycemic index
foods (and thus had a poorer-quality diet with respect to carbohydrate) in comparison to women who did not develop breast cancer
during follow-up, they may not have consumed these foods in

TABLE IV – ADJUSTED HAZARD RATIOS (95% CONFIDENCE INTERVALS) FOR THE ASSOCIATION BETWEEN GLYCEMIC LOAD (QUARTILES)
AND OVERALL GLYCEMIC INDEX AND RISK OF BREAST CANCER AMONG PREMENOPAUSAL WOMEN BY LEVELS
OF BODY MASS INDEX AND VIGOROUS PHYSICAL ACTIVITY
BMI (kg/m2)

No. of cases/person years

Glycemic load (g/day)
⬍ 125
125–147
148–169
⬎ 169

⬍ 25

ⱖ 25

448/266,991

1.0 (referent)
0.96 (0.73–1.27)
0.76 (0.57–1.02)
1.01 (0.76–1.35)
p ⫽ 0.70

Overall glycemic index
⬍ 63
1.0 (referent)
64–76
1.01 (0.73–1.40)
77–92
0.84 (0.56–1.26)
⬎ 92
0.89 (0.54–1.45)
p ⫽ 0.44

Vigorous physical Act
p for
interaction

None

Some

216/129,246

155/132,850

230/186,185

1.0 (referent)
0.94 (0.65–1.36)
0.92 (0.62–1.361)
0.85 (0.55–1.31)
p ⫽ 0.46

0.57

1.0 (referent)
0.92 (0.70–1.22)
0.87 (0.66–1.17)
0.93 (0.70–1.25)
p ⫽ 0.55

1.0 (referent)
0.97 (0.67–1.40)
0.69 (0.46–1.04)
0.92 (0.61–1.38)
p ⫽ 0.36

0.99

1.0 (referent)
0.85 (0.61–1.18)
0.71 (0.48–1.06)
0.71 (0.44–1.16)
p ⫽ 0.15

1.0 (referent)
1.11 (0.71–1.73)
0.80 (0.46–1.40)
0.81 (0.41–1.62)
p ⫽ 0.28

1.0 (referent)
0.84 (0.53–1.31)
0.65 (0.37–1.13)
0.62 (0.32–1.23)
p ⫽ 0.13

p for
interaction

0.70

0.74

Multivariable models included age (age at baseline), BMI in kg/m2 (⬍ 25, 25–29, ⱖ 30), alcohol (zero plus 4 levels of intake), use of oral
contraceptives (never plus 4 levels of duration), parity (zero plus 3 levels), age at menarche (ⱕ 12 vs. ⬎ 12 years of age), age at ﬁrst live birth
(⬍ 25, 25–29, ⱖ 30), ﬁrst-degree relative with breast cancer (yes/no), history of benign breast disease (yes/no), intake of energy (as a continuous
variable), energy-adjusted total ﬁber intake (as a continuous variable), study center and randomization group.
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TABLE V – ADJUSTED HAZARD RATIOS (95% CONFIDENCE INTERVALS) FOR THE ASSOCIATION BETWEEN GLYCEMIC LOAD (QUARTILES) AND
OVERALL GLYCEMIC INDEX AND RISK OF BREAST CANCER AMONG POSTMENOPAUSAL WOMEN BY LEVELS OF BODY MASS INDEX, VIGOROUS
PHYSICAL ACTIVITY AND HORMONE REPLACEMENT THERAPY USE

BMI (kg/m2)

Number of
cases/person
years

⬍ 25

ⱖ 25

321/503,391

251/299,799

Glycemic load (g/day)
⬍ 125
1.0 (referent)
125–147 1.29 (0.92–1.81)
148–169 1.06 (0.75–1.51)
⬎ 169
0.97 (0.68–1.39)
p ⫽ 0.48
Overall glycemic index
⬍ 63
1.0 (referent)
64–76
1.44 (0.94–2.23)
77–92
1.89 (1.14–3.13)
⬎ 92
1.99 (1.06–9.72)
p ⫽ 0.03

1.0 (referent)
1.08 (0.72–1.62)
1.36 (0.92–2.00)
1.22 (0.82–1.82)
p ⫽ 0.21
1.0 (referent)
1.39 (0.85–2.25)
1.63 (0.93–2.88)
1.57 (0.78–3.13)
p ⫽ 0.25

Vigorous physical activity
p for
interaction

None

Some

153/110,562

155/123,251

0.24

1.0 (referent)
1.0 (referent)
1.15 (0.84–1.56) 1.31 (0.81–2.12)
1.24 (0.91–1.68) 1.07 (0.64–1.76)
1.04 (0.76–1.42) 1.16 (0.69–1.93)
p ⫽ 0.80
p ⫽ 0.85

0.57

1.0 (referent)
1.0 (referent)
1.38 (0.94–2.03) 1.42 (0.80–2.52)
1.85 (1.19–2.89) 1.47 (0.73–2.94)
1.86 (1.07–3.21) 1.78 (0.76–4.18)
p ⫽ 0.02
p ⫽ 0.26

Hormone replacement therapy use

p for
interaction

Never

Ever

293/156,538

282/143,510

p for
interaction

0.65

1.0 (referent)
1.0 (referent)
1.08 (0.75–1.57) 1.27 (0.88–1.83)
1.06 (0.73–1.54) 1.34 (0.93–1.93)
0.94 (0.65–1.38) 1.20 (0.82–1.76)
p ⫽ 0.69
p ⫽ 0.37

0.93

0.55

1.0 (referent)
1.0 (referent)
1.46 (0.91–2.35) 1.43 (0.92–2.21)
1.85 (1.06–3.22) 1.75 (2.05–2.93)
1.58 (0.79–3.18) 2.15 (1.16–4.00)
p ⫽ 0.27
p ⫽ 0.02

0.50

Multivariable models included age (age at baseline), BMI in kg/m2 (⬍25, 25–29, ⱖ 30), alcohol (zero plus for levels of intake), use of
hormone replacement therapy (never plus four levels of duration), use of oral contraceptives (never plus four levels of duration), parity (zero
plus 3 levels), age at menarche (ⱕ 12 vs. ⬎ 12 years of age), age at ﬁrst live birth (⬍ 25, 25–29, ⱖ 30), ﬁrst degree relative with breast cancer
(yes/no), history of benign breast disease (yes/no), intake of energy (as a continuous variable), energy-adjusted total ﬁber intake (as a continuous
variable), study center and randomization group.

large enough quantities for glycemic load to have an effect on
breast cancer risk.
Given that high body mass index and lack of physical activity
are generally associated with increased fasting insulin26 and decreased insulin sensitivity,30 –32 women who are obese or who do
not participate in physical activity may have a more pronounced
insulin response to foods with higher glycemic values. Further,
high glycemic value diets are associated with higher free estrogen
levels due to the effect of insulin in lowering sex hormone-binding
globulin (SHBG) production31,33 and enhancing aromatization of
androgens.30,34 Hence, it is possible that postmenopausal women
who use hormone replacement therapy and whose diets are characterized by consumption of high glycemic index foods may be at
increased risk of hormone-mediated neoplasms, such as breast
cancer, due to greater exposure to free estrogen through a combination of pathways.
Previous studies of overall GI and GL have yielded mixed
results. For example, Augustin et al.,15 in a hospital-based casecontrol study of Italian women, reported statistically signiﬁcant
increased risks associated with the highest versus lowest quintile
level of both overall GI (OR ⫽ 1.36; 95% CI ⫽ 1.14 –1.64;
ptrend ⬍ 0.01) and GL (OR ⫽ 1.34; 95% CI ⫽ 1.10 –1.61; ptrend ⬍
0.01). In addition, the relationship between glycemic load/index
and breast cancer has been examined in 5 prospective studies.10 –14
In keeping with our ﬁndings, Holmes et al.,14 in an analysis of data
from the Nurses’ Health Study (NHS), which included 4,092
incident cases of breast cancer, observed no association between
glycemic load or overall glycemic index and risk of breast cancer
overall, but reported a borderline positive association between
overall glycemic index and breast cancer risk among postmenopausal women. In contrast, Jonas et al.12 and Folsom et al.,11 in
analyses of data from the CPS II Nutrition Cohort (1,442 incident
cases) and Iowa Women’s Health Study (2,031 incident cases),
respectively, reported no association between glycemic load/index
and breast cancer risk among postmenopausal women.
In the present study, there was some suggestion of an inverse
association between overall glycemic index and risk among premenopausal women. In contrast, Cho et al.,10 in an analysis of 714
incident breast cancer cases from the Nurses’ Health Study II, did
not ﬁnd any association between glycemic load/index among premenopausal women, and Higgenbotham et al.13 (946 incident
cases) reported a positive association between glycemic load and
risk among premenopausal women, but observed no association in
the total study population of pre- and postmenopausal women.

Three of the previous studies also examined dietary carbohydrate and/or dietary sugar intake in relation to breast cancer risk.
Holmes et al.14 found no association between either dietary carbohydrates or dietary ﬁber and breast cancer risk, whereas Cho et
al.10 reported an inverse association with carbohydrate intake
among premenopausal women with a BMI ⬍ 25 kg/m2 (ptrend ⫽
0.02). Augustin et al.15 reported a positive trend with white bread
consumption among postmenopausal women (ptrend ⫽ 0.02), but
not among premenopausal women (ptrend ⫽ 0.17), as well as
evidence of a positive association with sugar intake among both
pre- and postmenopausal women (ptrend ⫽ 0.09 and 0.03, respectively). In a recent case-control study, Romieu et al.35 also reported
a statistically signiﬁcant increased risk of breast cancer for the
highest versus the lowest quartile level of carbohydrate consumption (OR ⫽ 2.22; 95% CI ⫽ 1.63–3.04). Each of these studies
differed with respect to age at baseline, mean age at diagnosis
and/or the range of glycemic load/index values, both from each
other and from our study, making it difﬁcult to draw ﬁrm conclusions regarding the role of glycemic load in breast cancer etiology.
Our data are limited by the possibility of error with respect to
the measurement of diet and the calculation of glycemic load.
Error in the measurement of daily intake of carbohydrates and
sugars may have resulted from inaccurate recall.36 Furthermore,
measurement error might have occurred due to the fact that the
glycemic index values of some foods are currently based on only
1 or 2 often small studies.4 However, this applies to the previous
studies of glycemic index/load and breast cancer as well. Additional limitations include the fact that information on menopausal
status was collected only at baseline. Given that the minimum age
at baseline was 40 and an average of 16 years of follow-up, it is
likely that most of those who were premenopausal at enrollment
would have become postmenopausal during the course of followup. Thus, it is likely that our results for premenopausal women are
largely accounted for by a mix of breast cancers diagnosed preand postmenopausally. In addition, the results stratiﬁed by physical activity should be interpreted with caution given that approximately 22% of the study subjects were missing information on
physical activity. Also, although we adjusted our estimates for a
wide range of potentially confounding variables, uncontrolled confounding by dietary and other factors cannot be excluded.
In conclusion, the results of our study suggest that dietary
glycemic load is not associated with risk of breast cancer. In
contrast, while overall glycemic index was not associated with risk
of breast cancer in the total study population, a relatively high
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overall glycemic index might be associated with increased risk
among women who are postmenopausal, perhaps more so among
those who do not participate in vigorous physical activity or who
have ever used HRT. However, these observations require conﬁrmation in other studies.
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